| 2025-12-11 |
EXDO62Y0278630 |
DIRECT CUSTOMER SOLUTIONS LLC |
2088.0 kg |
310510.0
|
TENOFOVIR DISOPROXIL FUMARATE TABLETS HTS: |
| 2025-09-26 |
EXDO62Y0275812 |
DIRECT CUSTOMER SOLUTIONS LLC |
1905.0 kg |
291534.0
|
ABIRATERONE ACETATE TABS HTS: |
| 2025-09-02 |
EXDO62Y0275171 |
DIRECT CUSTOMER SOLUTIONS LLC |
4428.0 kg |
521042.0
|
EXEMESTANE TABLETS MG CT HTS: ABIRATERONE ACETATE TABS MG -CT HTS: |
| 2025-08-28 |
EXDO62Y0274812 |
HIKMA PHARMACEUTICALS USA INC |
2121.0 kg |
848041
|
OLANZAPINE FOR INJECTION MG/VIAL HTS: |
| 2025-07-06 |
EXDO62Y0271212 |
DIRECT CUSTOMER SOLUTIONS LLC |
2962.0 kg |
300439
|
ABIRATERONE ACETATE TABLETS HTS: 300439 EXEMESTANE TABLETS HTS: 300439 |
| 2025-07-06 |
EXDO62Y0271211 |
DIRECT CUSTOMER SOLUTIONS LLC |
1867.0 kg |
300439
|
ABIRATERONE ACETATE TABLETS HTS: 300439 |
| 2025-07-06 |
EXDO62Y0271289 |
DIRECT CUSTOMER SOLUTIONS LLC |
2098.0 kg |
300490
|
TENOFOVIR DISOPROXIL FUMARATE TABLETS HTS: 300490 |
| 2025-06-25 |
EXDO62Y0270803 |
HIKMA PHARMACEUTICALS USA INC |
3602.0 kg |
300420
|
MEROPENEM FOR INJECTION 500MG/VIAL HTS: 300420 |
| 2025-06-25 |
EXDO62Y0270805 |
HIKMA PHARMACEUTICALS USA INC |
1845.0 kg |
300420
|
MEROPENEM FOR INJECTION 500MG/VIAL HTS: 300420 |
| 2025-05-11 |
EXDO62Y0269111 |
DIRECT CUSTOMER SOLUTIONS LLC |
1874.0 kg |
300439
|
ABIRATERONE ACETATE TABLETS HTS: 300439 |
| 2025-05-07 |
EXDO62Y0269192 |
HIKMA PHARMACEUTICALS USA INC |
5312.0 kg |
300420
|
MEROPENEM FOR INJECTION HTS: 300420 ERTAPENEM FOR INJECTION HTS: 300420 |
| 2025-05-07 |
EXDO62Y0269200 |
HIKMA PHARMACEUTICALS USA INC |
5240.0 kg |
300420
|
MEROPENEM FOR INJECTION HTS: 300420 ERTAPENEM FOR INJECTION HTS: 300420 |
| 2025-05-07 |
EXDO62Y0269207 |
HIKMA PHARMACEUTICALS USA INC |
4849.0 kg |
300420
|
MEROPENEM FOR INJECTION HTS: 300420 |
| 2025-04-04 |
EXDO62Y0267487 |
HIKMA PHARMACEUTICALS USA INC |
1120.0 kg |
300420
|
ERTAPENEM FOR INJECTION HTS: 300420 |
| 2025-03-31 |
EXDO62Y0266815 |
DIRECT CUSTOMER SOLUTIONS LLC |
2799.0 kg |
300439
|
ABIRATERONE ACETATE TABLETS HTS: 300439 |
| 2025-03-31 |
EXDO62Y0266872 |
DIRECT CUSTOMER SOLUTIONS LLC |
1067.0 kg |
300490
|
TENOFOVIR DISOPROXIL FUMARATE TABLETS HTS: 300490 |
| 2025-03-31 |
EXDO62Y0267120 |
DIRECT CUSTOMER SOLUTIONS LLC |
2239.0 kg |
300490
|
EXEMESTANE TABLETS HTS: 300490 |
| 2025-03-15 |
EXDO62Y0265981 |
HIKMA PHARMACEUTICALS USA INC |
5352.0 kg |
848041
|
MEROPENEM FOR INJECTION HTS: |
| 2025-03-15 |
EXDO62Y0265980 |
HIKMA PHARMACEUTICALS USA INC |
5283.0 kg |
848041
|
MEROPENEM FOR INJECTION HTS: |
| 2025-03-15 |
EXDO62Y0265729 |
HIKMA PHARMACEUTICALS USA INC |
2587.0 kg |
848041
|
ERTAPENEM FOR INJECTION HTS: |
| 2025-03-15 |
EXDO62Y0265982 |
HIKMA PHARMACEUTICALS USA INC |
4494.0 kg |
848041
|
MEROPENEM FOR INJECTION HTS: |
| 2024-12-17 |
EXDO62Y0262389 |
DIRECT CUSTOMER SOLUTIONS LLC |
1669.0 kg |
291534
|
ABIRATERONE ACETATE TABS HTS: |
| 2024-02-25 |
EXDO62Y0247043 |
R&S SOLUTIONS LLC |
1624.0 kg |
291534
|
ABIRATERONE ACETATE TABS HTS: |
| 2024-01-07 |
EXDO62Y0244673 |
R&S SOLUTIONS LLC |
1747.0 kg |
291534
|
ABIRATERONE ACETATE TABS HTS: |
| 2023-12-18 |
EXDO62Y0243789 |
R&S SOLUTIONS LLC |
3330.0 kg |
310510
|
EXEMESTANE TABLETS 25MG 30CT HTS: |
| 2023-12-05 |
EXDO62Y0242646 |
R&S SOLUTIONS LLC |
1429.0 kg |
291534
|
ABIRATERONE ACETATE TABS HTS: |
| 2023-11-09 |
EXDO62Y0241881 |
R&S SOLUTIONS LLC |
1367.0 kg |
310510
|
EXEMESTANE TABLETS HTS: |
| 2023-10-26 |
EXDO62Y0240385 |
R&S SOLUTIONS LLC |
1759.0 kg |
291534
|
ABIRATERONE ACETATE TABS 250MG 120-CT HTS: |
| 2023-10-16 |
EXDO62Y0240042 |
R&S SOLUTIONS LLC |
6400.0 kg |
310510
|
TENOFOVIR DISOPROXIL FUMARATE TABLETS HTS: |
| 2023-08-08 |
EXDO62Y0237065 |
R&S SOLUTIONS LLC |
2820.0 kg |
520300
|
EXEMESTANE TABLETS 25MG 30CT HTS: ABIRATERONE ACETATE TABS 250MG 120-CT HTS: |
| 2023-06-09 |
EXDO62Y0234353 |
R&S SOLUTIONS LLC |
748.0 kg |
291534
|
ABIRATERONE ACETATE TABS HTS: |
| 2023-06-08 |
SNYLHTLCH230561 |
BAXTER HEALTHCARE CORP |
4500.0 kg |
293627
|
TAZOBACTAM ACID SET TEMP:+15 C VENT: CLOSED TAZOBACTAM ACID SET TEMP:+15 C VENT: CLOSED |
| 2023-04-17 |
EXDO62Y0232046 |
R&S SOLUTIONS LLC |
3206.0 kg |
310510
|
EXEMESTANE TABLETS 25MG 30CT HTS: ABIRATERONE ACETATE TABLETS 250MG 120-CT HTS: |
| 2022-12-03 |
EXDO62Y0226618 |
R&S SOLUTIONS LLC |
1880.0 kg |
310510
|
EXEMESTANE TABLETS HTS: |
| 2022-09-22 |
EXDO62Y0223410 |
R&S SOLUTIONS LLC |
2950.0 kg |
310510
|
TENOFOVIR DISOPROXIL FUMARATE TABLETS HTS: |
| 2022-08-12 |
EXDO62Y0220974 |
R&S SOLUTIONS LLC |
2353.0 kg |
291534
|
ABIRATERONE ACETATE TABS 250MG EXEMESTANE TABLETS 25MG |
| 2022-08-12 |
EXDO62Y0221904 |
R&S SOLUTIONS LLC |
3276.0 kg |
310510
|
TENOFOVIR DISOPROXIL FUMARATE TABLETS |
| 2021-12-27 |
EXDO62Y0204462 |
APOTEX CORP |
6795.0 kg |
848041
|
CEFAZOLIN FOR INJECTION |
| 2021-12-27 |
EXDO62Y0204461 |
APOTEX CORP |
6315.0 kg |
|
PIPERACIL/TAZO PINJ |
| 2021-12-27 |
EXDO62Y0204458 |
APOTEX CORP |
6315.0 kg |
|
PIPERACIL/TAZO PINJ |
| 2021-12-27 |
EXDO62Y0204460 |
APOTEX CORP |
6315.0 kg |
|
PIPERACIL/TAZO PINJ |
| 2021-12-27 |
EXDO62Y0204459 |
APOTEX CORP |
6315.0 kg |
|
PIPERACIL/TAZO PINJ |
| 2021-12-26 |
EXDO612364352 |
APOTEX CORP |
6399.0 kg |
848041
|
CEFEPIME FOR INJECTION 2G |
| 2021-12-26 |
EXDO612364353 |
APOTEX CORP |
6358.0 kg |
|
PIPERACIL/TAZO PINJ |
| 2021-12-26 |
EXDO612364354 |
APOTEX CORP |
6698.0 kg |
848041
|
CEFAZOLIN FOR INJECTION 1G |
| 2021-12-13 |
EXDO62Y0203562 |
APOTEX CORP |
6315.0 kg |
|
PIPERACIL/TAZO PINJ |
| 2021-12-13 |
EXDO62Y0203561 |
APOTEX CORP |
12630.0 kg |
|
PIPERACIL/TAZO PINJ PIPERACIL/TAZO PINJ |
| 2021-12-13 |
EXDO612364077 |
APOTEX CORP |
6315.0 kg |
280511
|
PIPERACILLIN SODIUM AND TAZOBACTAM SODIUM FOR INJECTION |
| 2021-11-26 |
EXDO62Y0202763 |
APOTEX CORP |
9245.0 kg |
848041
|
SOLIFENACIN SUCCINATE TABLETS CEFTRIAXONE FOR INJECTION |
| 2021-11-26 |
EXDO62Y0202738 |
APOTEX CORP |
18168.0 kg |
280511
|
PIPERACILLIN SODIUM AND TAZOBACTAM SODIUM FOR INJECTION PIPERACILLIN SODIUM AND TAZOBACTAM SODIUM FOR INJECTION |